Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Chinese scientists present new antiarrhythmic agent and effects on ischemia/reperfusion injury

June 1, 1999

Bosentan may represent new strategy for preventing cardiac and renal complications of hypertension

May 31, 1999

Enol metabolite of tasosartan appears not to contribute to pharmacodynamic effects

May 31, 1999

New, highly selective I1 receptor ligand with blood pressure-lowering effects

May 31, 1999

AGI-1067, a new vascular protectant, advances through the development pipeline

May 31, 1999

Long-term AT1 receptor blockade with fonsartan proves highly beneficial in SHR-SP

May 28, 1999

PD-098059 inhibits AII-induced MAPK activation in myocardial cells

May 28, 1999

Electrophysiological assessment of the sodium channel-blocking activity of RSD-921

May 26, 1999

Dietary omega-3 fatty acids have mild effect on coronary atherosclerosis

May 26, 1999

Transplantation news: neutrophil NADPH oxidase inhibitor improves functioning of preserved hearts

May 25, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...